Clinical Trial Details

EORTC-1617-QLG-BCG-ROG

Back to Clinical Trials Database

Follow-up in Early and Locally Advanced Breast Cancer Patients: An EORTC QLG-BCG- ROG Protocol

Study documentation

Trial Status Recruiting
Dates Date of activation: 14-Oct-2020
Data management at EORTC Yes
Design Cohort
Not randomized / N.A.
Targeted Sample size EORTC Groups: 830 - All Groups: 830
Treatment None
Study Staff Vesna Bjelic-Radisic (Study Coordinator) , Helios Klinikum Wuppertal - Klin. Univ. Witten / Herdecke, Wuppertal
Fatima Cardoso (Study Coordinator) , Champalimaud Clinical Center, Lisboa
Melanie Beauvois (Clinical Operations Manager) , EORTC Headquarters, Brussels
Andrew Bottomley (Clinical Research Physician) , EORTC Headquarters, Brussels
Christine Bourguignon (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Corneel Coens (Statistician) , EORTC Headquarters, Brussels
Coralie Poncet (Statistician) , EORTC Headquarters, Brussels
Gilles Sarlet (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Egle Venslovaite (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Tim Verbiest (Data Manager) , EORTC Headquarters, Brussels
Type of cancer Breast
Participating groups EORTC Breast Cancer Group
EORTC Quality of Life Group
EORTC Radiation Oncology Group
Recruiting centers Azienda Ospedaliero-Universitaria Careggi (Firenze, Italy)
Centre de radiotherapie Marie Curie (Arras, France)
Clinica Universidad de Navarra-Site Madrid (Madrid, Spain)
Complejo Hospitalario de Navarra (Pamplona, Spain)
Helios Klinikum Wuppertal - Klin. Univ. Witten / Herdecke (Wuppertal, Germany)
Hirslanden Klinik-Tumor Zentrum Aarau (Aarau, Switzerland)
Hospital Universitario Ramon y Cajal (Madrid, Spain)
Hospital Universitario Reina Sofia (Cordoba, Spain)
IRCCS - Istituto Oncologico Veneto (Padova, Italy)
Leeds Teaching Hospitals NHS Trust - St. James's University Hospital (Leeds, United Kingdom)
Leeds Teaching Hospitals NHS Trust - St. James's University Hospital (Leeds, United Kingdom)
Maria Sklodowska-Curie National Research Institute of Oncology (Warsaw, Poland)
Medical University Of Gdansk (Gdansk, Poland)
Ospedale Generale Regionale (Bolzano, Italy)
Ospedale San Gerardo (Monza, Italy)
The Great Poland Cancer Centre (Poznan, Poland)
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands)
Universitaetsklinikum Leipzig-Klinik fuer Strahlentherapie und Radioonkologie (Leipzig, Germany)
Centers to be activated Assistance Publique - Hopitaux de Paris - Hopital Tenon (Paris, France)
Barts Health NHS Trust - St. Bartholomew'S Hospital (London, United Kingdom)
C.H.U. Sart-Tilman (Liege, Belgium)
CHU Saint-Pierre-Site Porte de Hal (Brussels, Belgium)
CHU Site Sainte-Elisabeth-UCL Namur (Namur, Belgium)
Centro Hospitalar do Porto-- Hospital de Santo Antonio (Porto, Portugal)
Champalimaud Clinical Center (Lisboa, Portugal)
Champalimaud Clinical Center (Lisboa, Portugal)
Cliniques Universitaires Saint-Luc (Brussels, Belgium)
IRCCS - Fondazione G. Pascale (Napoli, Italy)
Institut de Cancerologie Strasbourg Europe (formar Paul Strauss) (Strasbourg, France)
Institut de Cancerologie Strasbourg Europe (formar Paul Strauss) (Strasbourg, France)
King Hussein Cancer Center (Amman, Jordan)
Klinicki Bolnicki Centar Rijeka (Rijeka, Croatia)
Onze Lieve Vrouw Ziekenhuis (Aalst, Belgium)
Sahlgrenska Universitetssjukhuset (Goteborg, Sweden)
Tumor and Breast Center ZeTuP St. Gallen (St Gallen, Switzerland)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
Universita Degli Studi Di Roma La Sapienza - Ospedale Sant'Andrea (Roma, Italy)
Universitaetsklinikum Wuerzburg (Wuerzburg, Germany)
Protocol summary http://clinicaltrials.gov/ct/show/NCT03859453
NCT number NCT03859453
Financial Support EORTC Group